Pharmaceutical Manufacturing Handbook: Production and

REFERENCES 643
97. Eden , S. ( 1979 ), Age and sex related differences in episodic growth hormone secretion
in the rat , Endocrinology , 105 , 555 – 560 .
98. Vermehren , C. , Hansen , H. S. , and Thomsen , M. K. ( 1996 ), Time dependent effects of
two absorption enhancers on the nasal absorption of growth hormone in rabbits , Int. J.
Pharm. , 128 , 239 – 250 .
99. Clausen , A. E. , and Schn ü rch - Bernkop , A. ( 2000 ), In vitro evaluation of permeation
enhancing effect of thiolated polycarbophil , J. Pharm. Sci. , 89 , 1253 – 1261 .
100. Schn ü rch - Bernkop , A. , and Steininger , S. ( 2000 ), Synthesis and characterization of
mucoadhesive thiolated polymers , Int. J. Pharm. , 194 , 239 – 247 .
101. Schn ü rch - Bernkop , A. , Zarti , H. , and Walker , G. F. ( 2001 ), Thiolation of polycarbophil
enhances its inhibition of soluble and intestinal brush border membrane bound aminopeptidase
N , J. Pharm. Sci. , 90 , 1907 – 1914 .
102. Clausen , A. E. , Kast , C. E. , and Schn ü rch - Bernkop , A. ( 2002 ), The role of glutathione in
the permeation enhancing effect of thiolated polymers , Pharm. Res. , 19 , 602 – 608 .
103. Schn ü rch - Bernkop , A. , Guggi , D. , and Pinter , Y. ( 2004 ), Thiolated chitosans: Development
and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery
system , J. Controlled Release , 94 , 177 – 186 .
104. Illum , L. ( 1996 ), Animal models for nasal delivery , J. Drug Target. , 3 , 717 – 724 .
105. Illum , L. , Watts , P. , Fisher , A. N. , Hinchcliffe , M. , Norbury , H. , Jabbal - Gill , I. , Nankervis ,
R. , and Davis , S. S. ( 2002 ), Intranasal delivery of morphine , J. Pharmcol. Exp. Ther. , 301 ,
391 – 400 .
106. Lindhardt , K. , Ó lafsson , D. R. , Gizurarson , S. , and Bechgaard , E. ( 2002 ), Intranasal bioavailability
of diazepam in sheep correlated to rabbit and man , Int. J. Pharm. , 231 ,
67 – 72 .
107. Kyrkou , M. , Harbord , M. , Kyrkou , N. , Kay , D. , and Coulthard , K. ( 2006 ), Community use
of intranasal midazolam for managing prolonged seizures , J. Intellect. Dev. Disabil. , 31 ,
131 – 138 .
108. Lui , C. Y. , Amidon , G. L. , and Goldberg , A. ( 1991 ), Intranasal absorption of fl urazepam,
midazolam and triazolam in dogs , J. Pharm. Sci. , 80 , 1125 – 1129 .
109. Olivier , J. C. , Djilani , M. , Fahmy , S. , and Couet , W. ( 2001 ), In situ nasal absorption of
midazolam in rats , Int. J. Pharm. , 213 , 187 – 192 .
110. Burstein , A. H. , Modica , R. , Hatton , M. , Forest , A. , and Gengo , F. M. ( 1997 ), Pharmcokinetics
and pharmacodynamics of midazolam after intranasal administration , J. Clin.
Pharmacol. , 37 , 711 – 718 .
111. Knoester , P. D. , Jonker , D. M. , van der Hoeven , R. T. M. , Vermeij , A. C. , Edelbroek ,
P. M. , Brekelmans , G. J. , and de Haan , G. J. ( 2002 ), Pharmacokinetics and pharmacodynamics
of midazolam administered as a concentrated intranasal spray. A study in healthy
volunteers , Br. J. Clin. Pharmcol. , 53 , 501 – 507 .
112. Allonen , H. , Ziegler , G. , and Klotz , U. ( 1981 ), Midazolam kinetics , Clin. Pharmacol. Ther. ,
30 , 653 – 661 .
113. Lindhardt , K. , Gizurarson , S. , Stefansson , S. , Olafsson , D. R. , and Bechgaard , E. ( 2001 ),
Electroencephalographic effects and blood levels after administration of diazepam to
humans , Br. J. Clin. Pharmcol. , 52 , 1 – 12 .
114. Eriksen , J. , Jensen , N. H. , Kamp - Jensen , M. , Bjarno , H. , Friis , P. , and Brewster , D. ( 1989 ),
The systemic availability of buprenorphine administered by nasal spray, J. Pharm. Pharmacol.,
41, 803 – 805 .
115. Shyu , W. C. , Mayol , R. F. , Pfeffer , M. , Pittman , K. A. , and Barbhiya , R. H. ( 1993 ), Biopharmaceutical
evaluation of transnasal, sublingual and buccal disk dosage forms of
butorphanol , Biopharm. Drug Dispos. , 14 , 371 – 379 .